Clinical Trials Browser

Phase 3 × NIH × Tumor Necrosis Factors × Clear all

NCT00003789 2013-07-16

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

Phase 3 Completed

Melanoma